Edition:
United Kingdom

People: Beijing Enterprises Medical and Health Industry Group Ltd (2389.HK)

2389.HK on Hong Kong Stock

0.24HKD
8:59am BST
Change (% chg)

HK$0.00 (+0.83%)
Prev Close
HK$0.24
Open
HK$0.24
Day's High
HK$0.24
Day's Low
HK$0.24
Volume
2,574,000
Avg. Vol
7,247,902
52-wk High
HK$0.40
52-wk Low
HK$0.20

Koepp, Robert 

Mr. Robert Winslow Koepp is Independent Non-Executive Director of the Company. Mr. Koepp obtained his bachelor’s degree in Asian Studies from the Pomona College, the United States and master’s degree in business administration from the Cambridge University in the United Kingdom. Mr. Koepp has in-depth professional experience in public and private equity financing, real estate, economics and business strategies, particularly for companies operating in China and listed overseas. He is the author of Betting on China: Chinese Stocks, American Stock Markets, and the Wagers on a New Dynamic in Global Capitalism among other publications. He has previously provided advice in the areas of investor relations and best practices for information disclosure to issuers which are principally engaged in the Chinese healthcare and consumer industries and are listed in The New York Stock Exchange and NASDAQ. Mr. Koepp has not had any executive or management role or functions in the Company, nor has he been under the employment of any member of the Company and has only attended meetings of the Board in the capacity of a non-executive Director. The Board considers that Mr. Koepp is independent and satisfies all the independence criteria in Rule 3.13 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited except Rule 3.13(7) in that he is a non-executive Director of the Company.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --